Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Blue Matter opens office in Boston 

By Brian Buntz | September 12, 2022

Blue MatterThe life sciences consulting firm Blue Matter has opened an office in Boston, Massachusetts.

The company also has offices in San Francisco, New York, London, Berlin, Zurich and Mumbai.

Headquartered in San Francisco, Blue Matter was founded in 2012.

“Over time, we have built a significant base of clients in the Boston area,” said Ashwin Dandekar, managing partner of Blue Matter, in a news release. “Our business there continues to grow rapidly, and we strongly believe that we can best serve our clients with teams that are located close by.”

The company had a remote team in place in Boston before opening the new office there. “But the team there has grown to a certain size, and the new office is a great thing for them,” Dandekar said. “There’s tremendous value in a shared space for collaborating on projects, meeting with clients, setting up our tools and resources, and fostering a team spirit. We maintain a flexible working environment, and the office is a key part of that.”

The company announced the opening of its Mumbai office on October 5, 2021.

The location in Mumbai also serves as an innovation lab to explore the development of new capabilities and service offerings.

The company has experience in various therapeutic areas, including oncology and rare diseases. Its website lists more than 10 therapeutic areas.

In January 2021, Blue Matter announced the launch of a new Center of Excellence focused on developing novel central nervous system (CNS) therapies.

“As more attention and investment is directed toward CNS, biopharma companies will need increasingly specialized support when it comes to commercial strategy,” said Dr. Varun Renjen, an associate principal in Blue Matter’s New York office, in a news release.

Also in January 2021, Blue Matter acquired the European supply chain consultancy AIM.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE